Skip to main content
. 2012 Jun 28;18(24):3081–3088. doi: 10.3748/wjg.v18.i24.3081

Table 1.

Clinicopathologic finding of 92 cases of pseudomyxoma peritonei n (%)

Index DPAM PMCA-I/D PMCA Total
No. of cases 49 (53.2)  26 (28.3)    17 (18.5) 92 (100.0)
Gender
Male 27 10 10 45 (48.9)
Female 22 16 7 47 (51.1)
Age (range, yr)  55.2 (22-79)    51.9 (24-76) 50.9 (31-75) 53.4 (22-79)
Operative times
≤ 2 34 18 12 64 (69.6)
> 2 15 8 5 28 (30.4)
Appendix
UR 1 0 1 2 (2.2)
UP 6 4 0 10 (10.9)
Appendicitis 1 1 1 3 (3.1)
LAMN 31 11 6 48 (52.2)
MACA 10 10 9 29 (31.5)
Architecture
Simple 15 0 0 15 (16.3)
FP 20 16 1 37 (40.2)
EP 4 10 4 18 (19.6)
Carcinomatous 0 0 12 12 (13.1)
Cytologic atypia
Minimal 45 12 1 58 (63.0)
Moderate 4 14 4 22 (23.9)
Marked 0 0 12 12 (13.1)
Mitosis
Rare 48 13 1 52 (56.5)
Occasional 1 10 7 18 (19.6)
Abundant 0 3 9 12 (13.1)
Organs involvment 2 3 10 15 (16.3)
Small intestine 11 1 52,3 7 (7.6)
Colon 0 1 33 4 (4.3)
Rectum 0 0 14 1 (1.1)
Urinary bladder 11 0 0 1 (1.1)
Liver 1 0 0 1 (1.1)
Uterus 0 1 14 2 (2.2)
Fallopian tube 0 0 1 1 (1.1)
Pleura 0 0 22 2 (2.2)
Ovarian involvment (n = 47) 13 12 7 32 (68.1)

1,2,3,4Represents one case had two organ involvement. LAMN: Low-grade appendiceal mucinous neoplasm; MACA: Mucinous adenocarcinoma; UP: Unknown pathology; UR: Unresected; FP: Focally proliferation; EP: Extensively proliferation; DPAM: Disseminated peritoneal adenomucinosis; PMCA-I/D: Peritoneal mucinous carcinomatosis with intermediate or discordant features.